Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Ergebnis 6 von 40

Details

Autor(en) / Beteiligte
Titel
The DNA methylation landscape of advanced prostate cancer
Ist Teil von
  • Nature genetics, 2020-08, Vol.52 (8), p.778-789
Ort / Verlag
New York: Nature Publishing Group US
Erscheinungsjahr
2020
Quelle
MEDLINE
Beschreibungen/Notizen
  • Although DNA methylation is a key regulator of gene expression, the comprehensive methylation landscape of metastatic cancer has never been defined. Through whole-genome bisulfite sequencing paired with deep whole-genome and transcriptome sequencing of 100 castration-resistant prostate metastases, we discovered alterations affecting driver genes that were detectable only with integrated whole-genome approaches. Notably, we observed that 22% of tumors exhibited a novel epigenomic subtype associated with hypermethylation and somatic mutations in TET2 , DNMT3B , IDH1 and BRAF . We also identified intergenic regions where methylation is associated with RNA expression of the oncogenic driver genes AR , MYC and ERG . Finally, we showed that differential methylation during progression preferentially occurs at somatic mutational hotspots and putative regulatory regions. This study is a large integrated study of whole-genome, whole-methylome and whole-transcriptome sequencing in metastatic cancer that provides a comprehensive overview of the important regulatory role of methylation in metastatic castration-resistant prostate cancer. Whole-genome bisulfite sequencing along with whole-genome and transcriptome sequencing of 100 prostate cancer metastases identifies genomic regions that are differentially methylated during disease progression and a novel epigenomic subtype.

Weiterführende Literatur

Empfehlungen zum selben Thema automatisch vorgeschlagen von bX